Publication | Closed Access

A Randomized Phase II Study of Two Schedules of Bryostatin-1 (NSC339555) in Patients with Advanced Malignant Melanoma – A National Cancer Institute of Canada Clinical Trials Group Study

MedicineCancer ManagementMelanomaAdvanced Malignant MelanomaDermatologyCancer TreatmentOncologyRadiation OncologyCancer Research